UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Journal of clinical oncology, 2019-07, Vol.37 (21), p.1810-1818

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2259-2265

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4649-4655

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3062-3068

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4626-4633

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2811-2818

2007

Link zum Volltext

Verfügbarkeit prüfen

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial

JNCI : Journal of the National Cancer Institute, 2015-09, Vol.107 (9), p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3104-3108

2009

Link zum Volltext

Verfügbarkeit prüfen

Ultra‐early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer

Cancer, 2010-02, Vol.116 (4), p.903-912

2010

Link zum Volltext

Verfügbarkeit prüfen

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control

American journal of obstetrics and gynecology, 2011-12, Vol.205 (6), p.509-510

McMeekin, D. Scott, MD

2011

Link zum Volltext

Verfügbarkeit prüfen

Vulvar cancer in young women: demographic features and outcome evaluation

American journal of obstetrics and gynecology, 2009-06, Vol.200 (6), p.645.e1-645.e5

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma

Obstetrics and gynecology (New York. 1953), 2007-05, Vol.109 (5), p.1062-1067

2007

Link zum Volltext

Verfügbarkeit prüfen

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

JNCI : Journal of the National Cancer Institute, 2017-03, Vol.109 (3), p.1-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Distance Traveled for Treatment of Cervical Cancer: Who Travels the Farthest, and Does it Impact Outcome?

International journal of gynecological cancer, 2013-07, Vol.23 (6), p.1099-1103

2013

Link zum Volltext

Verfügbarkeit prüfen

Does the Progression-Free Interval After Primary Chemotherapy Predict Survival After Salvage Chemotherapy in Advanced and Recurrent Endometrial Cancer?: A Gynecologic Oncology Group Ancillary Data Analysis

Cancer, 2010-12, Vol.116 (23), p.5407-5414

2010

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer metastatic to the brain: What is the optimal management?

Journal of surgical oncology, 2001-11, Vol.78 (3), p.194-200

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: A Gynecologic Oncology Group Study

Cancer, 2003-10, Vol.98 (8), p.1664-1669

2003

Link zum Volltext

Verfügbarkeit prüfen

Does the progression‐free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?

Cancer, 2010-12, Vol.116 (23), p.5407-5414

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of individual physicians on enrollment of patients into clinical trials

American journal of clinical oncology, 2003-04, Vol.26 (2), p.171-173

2003

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study

Obstetrical & gynecological survey, 2015-10, Vol.70 (10), p.626-628

2015

Link zum Volltext

Verfügbarkeit prüfen

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial

Obstetrical & gynecological survey, 2015-10, Vol.70 (10), p.624-626

2015

Link zum Volltext

Verfügbarkeit prüfen

The Survival Detriment of Venous Thromboembolism With Epithelial Ovarian Cancer

Obstetrical & gynecological survey, 2014-09, Vol.69 (9), p.543-544

2014

Link zum Volltext

Verfügbarkeit prüfen

A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome

Genes chromosomes & cancer, 2010-09, Vol.49 (9), p.791-802

2010

Link zum Volltext

Verfügbarkeit prüfen

Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer

Journal of the American College of Surgeons, 2001-12, Vol.193 (6), p.626-632

2001

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Chemotherapy for the Oldest Old Ovarian Cancer Patients : Can We Anticipate Toxicity-related Treatment Failure in a Vulnerable Population?

Cancer, 2009-04, Vol.115 (7), p.1472-1480

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

Ultra‐early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control

Vulvar cancer in young women: demographic features and outcome evaluation

Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

Distance Traveled for Treatment of Cervical Cancer: Who Travels the Farthest, and Does it Impact Outcome?

Does the Progression-Free Interval After Primary Chemotherapy Predict Survival After Salvage Chemotherapy in Advanced and Recurrent Endometrial Cancer?: A Gynecologic Oncology Group Ancillary Data Analysis

Ovarian cancer metastatic to the brain: What is the optimal management?

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: A Gynecologic Oncology Group Study

Does the progression‐free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?

Impact of individual physicians on enrollment of patients into clinical trials

A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial

The Survival Detriment of Venous Thromboembolism With Epithelial Ovarian Cancer

A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome

Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer

Adjuvant Chemotherapy for the Oldest Old Ovarian Cancer Patients : Can We Anticipate Toxicity-related Treatment Failure in a Vulnerable Population?

Aktive Filter

Suchergebnisse filtern